EMCDDA Home
  • EN
Search

Figure PPP-2. Indexed trends in EU potency/purity for major drug types, adjusting for population size, 2006–11

 
 
Drug type200620072008200920102011
Cannabis resin100101109106116120
Cocaine1001061018293105
Amphetamines1009465658388
Ecstasy100125108102130166

Notes:

1. The trends represent the available information on national potency / purity for each drug in the EU Member States and Norway, weighted by country population sizes to form an overall EU trend. All series indexed to a base of 100 in 2006.

2. Countries missing drug price information for two or more consecutive years are not included in the trend calculations: the trend for amphetamine on seventeen countries (65 % of the EU population 15-64), cocaine on twenty-one countries (82 % of the EU population 15-64), ecstasy on eighteen countries (59 % of the EU population 15-64), and cannabis resin on fifteen countries (58 % of the EU population 15-64). Trends for other drugs are not available due to insufficient data.

3. Additionally, where 2011 data are missing (one country) 2010 purity are used; for missing 2006 data (one countries) 2007 potency/purity data are used; data missing for other years (four countries) have been interpolated from adjacent years.

Sources:

Potency / purity data: Reitox National Focal Points

Drug type 2006 2007 2008 2009 2010 2011
Cannabis resin 100 101 109 106 116 120
Cocaine 100 106 101 82 93 105
Amphetamines 100 94 65 65 83 88
Ecstasy 100 125 108 102 130 166

pppfig2

 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 08 May 2013